Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial.
Feig D, Sanchez J, Murphy K, Astalos E, Zinman B, Sinmons D et al.
Lancet Diabetes Endocrinol. 2023 Mar;11(3):191-202.
www.doi.org/10.1016/S2213-8587(23)00004-9
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled In Range trial
Battelino T, Danne T, Edelman S, Choudhary P, Renard E et al
Diabetes, obesity and metabolism
https://doi.org/10.1111/dom.14898
Standards of Care in Diabetes-2023
Diabetes Care December 2022, Vol.46, S1-S284
https://doi.org/10.2337/dc23-Sint
Fasting and meal-stimulated serum C-peptide in long-standing type 1 diabetes mellitus
Vollenbrock C, Mul D, Dekker P, Birnie E, de Vries-Velraeds M, Boesten et al
Diabetic Medicine
https://www.doi.org/10.1111/dme.15012
Optimal Frequency of Urinary Albumin Screening in Type 1 Diabetes
Perkins B, BebuI, de Boer I, Molitch M, Zinman B, Bantle J, Nathan D
Diabetes Care 2022;45(12):2943–2949
https://www.doi.org/10.2337/dc22-1420
Empagliflozin in Patients with Chronic Kidney Disease
The EMPA-KIDNEY Collaborative Group
N Engl J Med. 2022 Nov 4.
https://doi.org/10.1056/NEJMoa2204233
Comentarios recientes